Skip Navigation

Cardiovascular Research 1998 39(1):165-177; doi:10.1016/S0008-6363(97)00313-1
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Janse, M. J.
Right arrow Articles by Kléber, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janse, M. J.
Right arrow Articles by Kléber, A. G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Animal models of cardiac arrhythmias1

Michiel J. Jansea,*, Tobias Opthofa and André G. Kléberb

aDepartment of Clinical and Experimental Cardiology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands
bPhysiologisches Institut, Universität Bern, Bern, Switzerland

* Corresponding author.

Received 8 October 1997; accepted 3 December 1997

The first 150 words of the full text of this article appear below.


    1 Introduction
 
When surveying the literature with the intention of evaluating to which extent studies on animal models have contributed to the understanding of arrhythmia mechanisms in patients and in devising therapeutic strategies, one is struck by the differences between supraventricular and ventricular arrhythmias. In general, in the field of supraventricular arrhythmias there has been a strong interaction between experimental and clinical studies and there can be no doubt that the various animal models have been instrumental in understanding the mechanisms of clinical arrhythmias and in establishing different forms of therapy. Clearly, an animal cannot be transformed into a human patient, but despite species differences and differences in arrhythmogenic factors in animal models and humans, the similarity between arrhythmia mechanisms in experimental models and patients far outweigh the differences.

This similarity is less evident when considering ventricular arrhythmias. There are several reasons for this. First, many ventricular arrhythmias, such as those induced . . . [Full Text of this Article]


    2 Supraventricular arrhythmias
 
2.1 Re-entrant tachycardias in the presence of accessory atrioventricular pathways
2.2 Atrioventricular nodal re-entrant tachycardia
2.3 Atrial flutter
2.4 Atrial fibrillation

    3 Ventricular arrhythmias
 
3.1 A hereditary model of sudden death
3.2 Ventricular arrhythmias caused by acute ischaemia
3.3 The ventricular arrhythmias of myocardial infarction
3.4 Animal models and antiarrhythmic drugs

    4 Conclusions
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Ehrlich, C. Hoche, P. Coutu, C. Metz-Weidmann, W. Dittrich, S. H. Hohnloser, S. Nattel, and H. Gogelein
Properties of a Time-Dependent Potassium Current in Pig Atrium: Evidence for a Role of Kv1.5 in Repolarization
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. F. Kwaku
Cell Therapy for Rate Control in Atrial Fibrillation: A New Approach to an Old Problem
Circulation, May 30, 2006; 113(21): 2474 - 2476.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Canyon and G. P. Dobson
Protection against ventricular arrhythmias and cardiac death using adenosine and lidocaine during regional ischemia in the in vivo rat
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1286 - H1295.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. A. Wellenius, J. R. F. Batalha, E. A. Diaz, J. Lawrence, B. A. Coull, T. Katz, R. L. Verrier, and J. J. Godleski
Cardiac Effects of Carbon Monoxide and Ambient Particles in a Rat Model of Myocardial Infarction
Toxicol. Sci., August 1, 2004; 80(2): 367 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Mancuso, D. R. Abendschein, C. M. Jenkins, X. Han, J. E. Saffitz, R. B. Schuessler, and R. W. Gross
Cardiac Ischemia Activates Calcium-independent Phospholipase A2{beta}, Precipitating Ventricular Tachyarrhythmias in Transgenic Mice: RESCUE OF THE LETHAL ELECTROPHYSIOLOGIC PHENOTYPE BY MECHANISM-BASED INHIBITION
J. Biol. Chem., June 13, 2003; 278(25): 22231 - 22236.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. I. Berul
Electrophysiological phenotyping in genetically engineered mice
Physiol Genomics, May 13, 2003; 13(3): 207 - 216.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Duru, M. Barton, and R. Candinas
Re: 'Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three dimensional mapping' (Cardiovasc Res 2000;45:310-320)
Cardiovasc Res, June 1, 2000; 46(3): 604 - 605.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. A. Grace and A.J. Camm
Voltage-gated calcium-channels and antiarrhythmic drug action
Cardiovasc Res, January 1, 2000; 45(1): 43 - 51.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. G Kleber
ST-segment elevation in the electrocardiogram: a sign of myocardial ischemia
Cardiovasc Res, January 1, 2000; 45(1): 111 - 118.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X. H.T. Wehrens, S. Kirchhoff, and P. A. Doevendans
Mouse electrocardiography: An interval of thirty years
Cardiovasc Res, January 1, 2000; 45(1): 231 - 237.
[Abstract] [Full Text] [PDF]